Identification of protein profile in metacyclic and amastigote-like stages of Leishmania tropica: a proteomic approach.
Leishmania tropica
Leishmaniasis
Proteomics
SWATH-MS
Journal
AMB Express
ISSN: 2191-0855
Titre abrégé: AMB Express
Pays: Germany
ID NLM: 101561785
Informations de publication
Date de publication:
12 Nov 2022
12 Nov 2022
Historique:
received:
22
05
2022
accepted:
23
10
2022
entrez:
12
11
2022
pubmed:
13
11
2022
medline:
13
11
2022
Statut:
epublish
Résumé
Leishmaniasis is a tropical disease that leads to various clinical phenotypes. This study aimed to investigate protein expression changes in metacyclic and amastigote-like stages of L. tropica isolated from Iranian cutaneous leishmaniasis patients. Isolated samples were cultured and species type identified using PCR-RFLP technique. The promastigotes were grown in RPMI1640 media and differentiated to metacyclic and amastigote-like forms, followed by the extracted proteins of both successive stages carried out for proteomics and bioinformatics analysis. Using SWATH-MS quantitative proteomics technique, a total 176 and 155 distinct proteins were identified in metacyclic and axenic amastigote stages, respectively. Of these, 65 proteins were altered significantly (p-value < 0.05 and fold change ≥ 2) between studied stages. Several gene ontology (GO) categories were enriched for biological process during conversion of metacyclic promastigotes into amastigote-like, which "metabolic process" (GO: 0044281, P-Value: 6.52e-5), and "translation" (GO: 0006412, p-value: 5.01e-14) were disclosed as the top category in up and down-regulated proteins, respectively. Also, the KEGG pathway analysis indicated "metabolic pathways" and "ribosome" term as the most important pathways in up and down-regulated proteins, respectively. According to protein interaction network analysis, enolase (ENOL) has been detected as main hub proteins during differentiation, followed by Putative NADH-dependent fumarate reductase (LmjF.35.1180) and 40S ribosomal protein S2 (LmjF.32.0450). Overall, protein changes possibly play important roles in L. tropica biology. Anabolic pathways were down-regulated, whereas catabolic pathways were up-regulated during L. tropica differentiation. These protein expression changes could provide parasite survival in host macrophages, and could use as novel potential drug and vaccine targets for leishmaniasis.
Identifiants
pubmed: 36370199
doi: 10.1186/s13568-022-01481-z
pii: 10.1186/s13568-022-01481-z
pmc: PMC9653527
doi:
Types de publication
Journal Article
Langues
eng
Pagination
142Informations de copyright
© 2022. The Author(s).
Références
East Mediterr Health J. 2012 Feb;18(2):165-71
pubmed: 22571094
Biochem J. 1995 Jan 1;305 ( Pt 1):307-13
pubmed: 7826346
FASEB J. 2008 Feb;22(2):590-602
pubmed: 17884972
Acta Trop. 2020 Feb;202:105227
pubmed: 31647897
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Expert Rev Proteomics. 2018 May;15(5):371-390
pubmed: 29717934
Clin Dermatol. 1996 Sep-Oct;14(5):417-23
pubmed: 8889319
Microbes Infect. 2013 Jul-Aug;15(8-9):579-91
pubmed: 23628411
Med Microbiol Immunol. 2001 Nov;190(1-2):77-9
pubmed: 11770116
BMC Bioinformatics. 2003 Jan 13;4:2
pubmed: 12525261
Proteomics. 2002 Aug;2(8):1007-17
pubmed: 12203896
Microb Pathog. 2020 Dec;149:104557
pubmed: 33017654
J Proteome Res. 2018 Mar 2;17(3):1194-1215
pubmed: 29332401
Mol Biochem Parasitol. 2004 Jul;136(1):51-62
pubmed: 15138067
J Protozool. 1976 Nov;23(4):600-7
pubmed: 1003346
Exp Parasitol. 1985 Apr;59(2):151-60
pubmed: 2982638
Exp Parasitol. 1999 Apr;91(4):341-8
pubmed: 10092478
J Biomed Biotechnol. 2010;2010:840518
pubmed: 19911078
Nucleic Acids Res. 2003 Jan 1;31(1):258-61
pubmed: 12519996
BMC Bioinformatics. 2010 Sep 27;11:484
pubmed: 20875130
Phys Rev E Stat Nonlin Soft Matter Phys. 2006 Sep;74(3 Pt 2):036104
pubmed: 17025705
Curr Med Chem. 2009;16(5):599-614
pubmed: 19199925
Exp Parasitol. 2009 Sep;123(1):51-7
pubmed: 19500579
Nucleic Acids Res. 2010 Jan;38(Database issue):D457-62
pubmed: 19843604
Enzyme Res. 2011;2011:932549
pubmed: 21603223
Galen Med J. 2019 Aug 15;8:e1520
pubmed: 34466522
Iran J Parasitol. 2015 Oct-Dec;10(4):530-40
pubmed: 26811718
Mol Biochem Parasitol. 2007 Mar;152(1):53-65
pubmed: 17204342
Proteomics. 2003 Sep;3(9):1811-29
pubmed: 12973740
Science. 1985 Sep 13;229(4718):1099-101
pubmed: 4035350
J Parasitol. 1998 Jun;84(3):644-7
pubmed: 9645879
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5502-7
pubmed: 16569701
FASEB J. 2011 Feb;25(2):515-25
pubmed: 20952481
Galen Med J. 2018 Jun 12;7:e1129
pubmed: 34466438
Evid Based Complement Alternat Med. 2018 Mar 28;2018:6813467
pubmed: 29785196
East Mediterr Health J. 2013 Oct;19(10):847-53
pubmed: 24313148
Nature. 2001 May 3;411(6833):41-2
pubmed: 11333967
Exp Parasitol. 1982 Dec;54(3):397-409
pubmed: 7151947
Iran J Parasitol. 2015 Oct-Dec;10(4):599-604
pubmed: 26811727
Mol Biochem Parasitol. 2010 Feb;169(2):108-14
pubmed: 19900490